What is the recommended management of acute diarrhea, including fluid replacement, diet, anti‑motility therapy, and criteria for antibiotic use?

Management of Acute Diarrhea

Oral rehydration solution (ORS) is the cornerstone of acute diarrhea management for mild-to-moderate dehydration, while empiric antibiotics are generally not recommended for most cases of acute watery diarrhea without recent international travel. 1

Fluid Replacement Strategy

Mild to Moderate Dehydration

• Reduced osmolarity ORS is first-line therapy for all patients with mild-to-moderate dehydration from acute diarrhea, regardless of age or etiology 1
• Continue ORS until clinical dehydration is corrected, then maintain with ORS to replace ongoing stool losses until diarrhea resolves 1
• For patients unable to tolerate oral intake, nasogastric ORS administration may be considered in those with normal mental status 1

Severe Dehydration

• Isotonic intravenous fluids (lactated Ringer's or normal saline) are required when severe dehydration, shock, altered mental status, ORS failure, or ileus is present 1
• Continue IV rehydration until pulse, perfusion, and mental status normalize, then transition to ORS for remaining deficit replacement 1
• Patients with ketonemia may need initial IV hydration to enable oral tolerance 1

Common pitfall: Oral rehydration is often underutilized in favor of IV fluids. ORS is equally effective for mild-to-moderate dehydration and should be the default approach. 2

Dietary Management

• Continue breastfeeding throughout the diarrheal episode in infants and children 1
• Resume age-appropriate usual diet immediately during or after rehydration is completed 1
• Early refeeding is preferred over prolonged dietary restriction 3

Key principle: The outdated practice of prolonged dietary restriction should be abandoned. Normal feeding supports intestinal recovery and nutritional status. 1

Anti-Motility Therapy

Adults

• Loperamide may be given to immunocompetent adults with acute watery diarrhea as symptomatic therapy once adequately hydrated 1
• Absolutely avoid loperamide in inflammatory diarrhea, bloody diarrhea, or fever due to risk of toxic megacolon 1
• Loperamide can help decrease inappropriate antibiotic use by providing symptom relief 2

Children

• Antimotility drugs should NOT be given to children <18 years of age with acute diarrhea 1

Antiemetics

• Ondansetron may be given to children >4 years and adolescents with vomiting to facilitate oral rehydration tolerance 1

Critical safety point: Never use antimotility agents when bloody diarrhea, high fever, or suspected inflammatory/invasive pathogens are present, as this increases risk of complications including toxic megacolon and hemolytic uremic syndrome. 1

Criteria for Antibiotic Use

Acute Watery Diarrhea (WITHOUT Blood)

Empiric antibiotics are NOT recommended for most patients with acute watery diarrhea without recent international travel 1

Exceptions where empiric treatment may be considered:

• Immunocompromised patients 1
• Ill-appearing young infants 1

Avoid empiric antibiotics in persistent watery diarrhea lasting ≥14 days 1

Bloody Diarrhea (Dysentery)

Empiric antibiotics are generally NOT recommended while awaiting test results, except in these specific scenarios: 1

Indications for empiric antibiotics in bloody diarrhea:

• Infants <3 months with suspected bacterial etiology 1
• Ill immunocompetent patients with documented fever in medical setting, abdominal pain, bloody diarrhea, and bacillary dysentery (frequent scant bloody stools, fever, cramps, tenesmus) presumed to be Shigella 1
• Recent international travelers with temperature ≥38.5°C or signs of sepsis 1
• Immunocompromised patients with severe illness and bloody diarrhea 1
• Suspected enteric fever with sepsis features 1

Empiric antibiotic choices:

• Adults: Fluoroquinolone (ciprofloxacin) or azithromycin, based on local susceptibility patterns and travel history 1
• Children: Third-generation cephalosporin for infants <3 months or those with neurologic involvement; azithromycin for others, based on local susceptibility and travel history 1

Critical Contraindication

Avoid antibiotics in STEC O157 and other STEC producing Shiga toxin 2 (or unknown toxin genotype) due to increased risk of hemolytic uremic syndrome 1

Modification of Therapy

• Modify or discontinue antibiotics when a specific organism is identified through testing 1
• Narrow broad-spectrum therapy based on susceptibility results 1

Evidence strength note: The 2017 IDSA guidelines provide the most comprehensive, evidence-based framework for antibiotic decision-making in infectious diarrhea, with strong recommendations against routine empiric use in most cases. 1

Adjunctive Therapies

Probiotics

• May be offered to reduce symptom severity and duration in immunocompetent patients with infectious or antibiotic-associated diarrhea 1
• Evidence quality is moderate but effect sizes are modest 3

Zinc Supplementation

• Reduces diarrhea duration in children 6 months to 5 years in countries with high zinc deficiency prevalence or signs of malnutrition 1
• Not routinely recommended in well-nourished children in developed countries 1

Key Clinical Pearls

When to pursue diagnostic testing: Reserve stool studies for severe dehydration, persistent fever, bloody stools, immunosuppression, suspected nosocomial infection, or outbreak situations 2, 4, 3

Asymptomatic contacts: Do not treat empirically; advise infection control measures and hand hygiene 1

Most critical intervention: Adequate hydration prevents morbidity and mortality more effectively than any other intervention, including antibiotics 1, 2